Organ-on-chip (OoC) platforms are increasingly adopted for predictive in vitro testing. However, most remain limited by soft-lithography-derived 2.5D microfluidic architectures and nonphysiological rigid materials, or bioprinting approaches that require comple... ...

请注册登录后继续浏览